Skip to main content
Cureus logoLink to Cureus
. 2024 Feb 22;16(2):e54677. doi: 10.7759/cureus.54677

ECG Changes Post-pericardiocentesis for Cardiac Tamponade Secondary to Non-small Cell Carcinoma of the Lung

Kyle Aldridge 1,2,, Kevin E Guzman 3,2, Russell W Barry 1,2, Margaret A Franklin Christian 1,2, Felipe Ruiz 4, Ilya Fonarov 2, Damian Casadesus 2
Editors: Alexander Muacevic, John R Adler
PMCID: PMC10960619  PMID: 38523986

Abstract

Electrical alternans on electrocardiograph (ECG) is an uncommon but nearly pathognomonic sign of cardiac tamponade. Here, we present a male quadragenarian who came to the emergency department complaining of low back and right upper abdominal pain. Work-up revealed a large pericardial effusion associated with electrical alternans on ECG and clinical findings of cardiac tamponade. Pericardiocentesis drained approximately 1 liter of hemorrhagic fluid with resolution of cardiac tamponade and normalization of the ECG. Further evaluation with right hilar lymph node biopsy confirmed a diagnosis of poorly differentiated non-small cell adenocarcinoma of the lung.

Keywords: non-small cell carcinoma, pericardiocentesis, ecg, electrical alternans, cardiac tamponade

Introduction

Cardiac tamponade is a life-threatening condition characterized by the abnormal accumulation of fluid in the pericardial space. It is common for patients to present in distress and they often complain of chest pain and dyspnea. Physical exam findings reflect the decreased filling capacity of the heart chambers, leading to tachycardia, hypotension, jugular venous distension, and pulsus paradoxus [1]. Findings on electrocardiograph (ECG) may include electrical alternans, low QRS voltage, P wave, and T wave changes [2]. Here, we showcase the resolution of electrical alternans on ECG after pericardial effusion drainage.

Case presentation

A male in his 40s with no significant past medical history presented to the emergency department complaining of lower back and right upper abdominal pain. He reported nausea and vomiting for four days preceding the visit, along with a cough. He denied any fever, weight loss, chest pain, or shortness of breath. He did not have any history of tobacco use but engages in social alcohol consumption and smokes marijuana weekly. While in the emergency room, he was afebrile and tachycardic at 121 beats per minute and had a blood pressure of 96/64 mmHg. A cardiopulmonary exam revealed distant heart sounds. The patient had 2+ pedal edema. Abdominal exam elicited tenderness in the right upper quadrant without rebound or guarding and a negative Murphy’s sign.

Pertinent laboratory data can be found in Table 1. Interferon-gamma release assay (IGRA) QuantiFERON Gold Plus I blood test was negative. Testing for COVID-19, influenza (A and B), and respiratory syncytial virus (RSV) were negative. 

Table 1. Pertinent laboratory findings.

BUN: blood urea nitrogen, CRP: C-reactive protein, BNP:  B-type natriuretic peptide, AST: aspartate aminotransferase, ALT: alanine transaminase, ALP: alkaline phosphatase, LDH: lactic dehydrogenase, CPK: creatine phosphokinase, LDH: lactic dehydrogenase, INR: international normalized ratio

Investigation Patient values Reference values
BUN 23 mg/dL 6-24 mg/dL
Creatinine 1.9 mg/dL 0.7-1.3 mg/dL
CRP 5.6 mg/dL <0.3 mg/dL
Hemoglobin 10.8 g/dL 13.8-17.2 g/dL
Hematocrit 33.7% 41-50%
Platelets 204 x 109/L 150-450 x 109/L
Leukocytes 10.3 x 109/L 4.5-11 × 109/L
Troponin <0.012 ng/mL <0.04 ng/mL
BNP 113 pg/mL <100 pg/mL
AST 4608 U/L 8-33 U/L
ALT 2134 U/L 7-56 U/L
ALP 105 U/L 44-147 U/L
LDH 5,299 U/L 105-233 U/L
Total protein 5.2 g/dL 6.0-8.3 g/dL
Albumin 2.6 g/dL 3.4-5.4 g/dL
CPK 479 mcg/L 10-120 mcg/L
LDH 5,299 U/L 140-280 U/L
INR 1.81 <1.1

The initial ECG (Figure 1) demonstrated sinus tachycardia with a shortened PR interval and variation in the amplitude of the R wave consistent with electrical alternans. Computerized tomography (CT) with contrast of the chest, abdomen, and pelvis revealed large bilateral pleural effusions (Figure 2), a large pericardial effusion (Figure 3), and hepatic congestion with a nutmeg appearance. In addition, there was enhancing prominent mediastinal lymphadenopathy and an enlarged right hilar lymph node concerning for a neoplastic process.

Figure 1. Electrical alternans on initial ECG .

Figure 1

Figure 2. Bilateral pleural effusions (white arrows) with prominent right hilar lymph node (red arrow) visualized on CT.

Figure 2

Figure 3. Large pericardial effusion visualized on CT .

Figure 3

An echocardiogram reported a left ventricular ejection fraction of 55-60%. There was a large pericardial effusion (Figure 4), and the inferior vena cava was dilated and lacked inspiratory variation (Figure 5), indicating cardiac tamponade. 

Figure 4. Large pericardial effusion visualized on echocardiography.

Figure 4

Figure 5. Dilated inferior vena cava visualized on echocardiography.

Figure 5

A pericardiocentesis was immediately performed. Approximately 1 liter of hemorrhagic fluid was removed. Cell counts of the pericardial aspirate can be found in Table 2. Malignant cells were found on cytological analysis of the fluid.

Table 2. Pericardial fluid analysis.

RBC: red blood cell, LDH: lactate dehydrogenase

Investigation  Patient values  Reference values
RBC 2,049,527/mm3 0
Nucleated cells 8,318/mm3 <200/mm3
LDH 5299 U/L 141-2613 U/L
Glucose 14 mg/dL 80-134 mg/dL

An ECG obtained following the procedure showed sinus tachycardia and resolution of the electrical alternans (Figure 6).

Figure 6. Repeat ECG obtained after pericardial fluid drainage without R wave amplitude variation .

Figure 6

The patient was placed on colchicine and furosemide as adjuvant therapies.

A CT of the chest with contrast two days after admission revealed prominent mediastinal lymphadenopathy and an enlarged, enhancing left supraclavicular lymph node. In addition, several small pulmonary nodules in the right lung were identified. The investigation continued with a biopsy of the right hilar lymph node. Pathological findings indicated poorly differentiated infiltrative non-small cell carcinoma (Figure 7) with immunohistochemistry staining, suggesting a pulmonary origin (Figures 8, 9).

Figure 7. Hematoxylin and eosin-stained tissue section shows a poorly differentiated infiltrative non-small cell carcinoma (H&E; 200x).

Figure 7

Figure 8. Keratin 7-positive immunohistochemistry staining favors pulmonary origin adenocarcinoma (IHC; 200x).

Figure 8

Figure 9. Thyroid transcription factor 1-positive immunohistochemistry staining favors pulmonary origin adenocarcinoma (IHC; 200x).

Figure 9

Our patient’s symptoms progressively improved over the next few days. The aspartate aminotransferase (AST) and alanine aminotransferase (ALT) improved to 82 U/L and 265 U/L, respectively.

Oncology was consulted and made recommendations for treatment. The patient declined further intervention and decided to pursue outpatient palliative care. He was discharged from the hospital in stable condition.

Discussion

Electrical alternans is an ECG finding often associated with large pericardial effusions [3]. The sign is defined as an alternating height of electrical complexes arising from the same pacemaking site. Any ECG wave can show this change, but it is most often observed with the QRS complex [1]. A mechanism that contributes to this finding is the pendular motion of the heart throughout the cardiac cycle from accumulated pericardial fluid [4]. Although electrical alternans is typically associated with pericardial effusion, it has also been observed in other pathologies, such as immediately preceding ventricular fibrillation and during catecholaminergic states [5]. If the finding is associated with pericardial effusion, it can disappear following adequate drainage [6].

Large pericardial effusions result in cardiac tamponade in about 25% of cases [7]. A weakened apical pulse, distant heart sounds, pulsus paradoxus, and narrow pulse pressure mark the syndrome. Cardiac tamponade results in a life-threatening state of reduced venous return and impaired diastolic functioning. The ensuing shock can be fatal [7].

There are many etiologies of pericardial effusion. Pericarditis, autoimmune disease, and malignancy are frequent causes. Malignant involvement of the pericardium is common, but the treatment of the malignancy itself is another possible culprit [8].

The diagnosis of cardiac tamponade requires a high degree of clinical suspicion. ECG can be a vital tool in diagnosis. Signs indicating cardiac tamponade include low QRS voltage, PR segment depression, sinus tachycardia, and electrical alternans. An echocardiogram could report a swinging heart, right atrial systolic collapse, right ventricular free wall diastolic collapse, enlarged and non-pulsatile inferior vena cava, and the presence of fluid in the pericardial space. Advanced imaging techniques are occasionally used. A CT or MRI may show deformed cardiac chambers and distention of the vena cava [9].

Cardiac tamponade requires immediate drainage to avoid life-threatening complications. Ultrasound-guided pericardiocentesis is an effective procedure to alleviate this condition. Fluid removal should be less than 1 liter to avoid right ventricular dilation that can result in profound hypotension. Other possible treatment options include subxiphoid surgical drainage, pericardial window technique, and left anterior minithoracotomy [10]. There is evidence that pericardiocentesis followed by continuous negative pressure drainage via a pigtail catheter can result in better patient outcomes [11].

The optimal management of malignant pericardial effusion is debated. The creation of a pericardial window is frequently used to prevent effusion recurrence. Despite this definitive procedure, the prognosis is extremely poor in the postoperative period. Most patients with malignant effusion experience only three months of survival [12]. Adjuvant therapy to prevent effusion recurrence includes systemic or intrapericardial antineoplastics or anti-inflammatory medications. Colchicine was used in our patient. This drug is highly beneficial in inflammatory pericardial effusion but has shown limited success in malignant effusion [13].

Conclusions

Electrical alternans is a unique ECG finding often associated with large pericardial effusions. Our patient presented in cardiac tamponade with electrical alternans on ECG. After adequate pericardial fluid drainage, the sign resolved. Further evaluation resulted in a diagnosis of lung adenocarcinoma. Our patient decided to pursue palliative care in the outpatient setting after inpatient stabilization. Pericardial effusion resulting in cardiac tamponade has many etiologies. Although optimal chronic care of malignant pericardial effusion is debated, acute treatment requires drainage of pericardial fluid to avoid life-threatening complications.

Acknowledgments

The following co-authors participated in the original manuscript but did not participate in this revision: Emily Finkelstein, Brian Massa-Peña, and Colton Hawco.

The authors have declared that no competing interests exist.

Author Contributions

Concept and design:  Kyle Aldridge, Russell W. Barry, Margaret A. Franklin Christian, Kevin E. Guzman, Damian Casadesus, Ilya Fonarov

Acquisition, analysis, or interpretation of data:  Kyle Aldridge, Ilya Fonarov, Felipe Ruiz

Drafting of the manuscript:  Kyle Aldridge, Ilya Fonarov

Critical review of the manuscript for important intellectual content:  Kyle Aldridge, Russell W. Barry, Margaret A. Franklin Christian, Kevin E. Guzman, Damian Casadesus, Ilya Fonarov, Felipe Ruiz

Supervision:  Damian Casadesus, Ilya Fonarov

Human Ethics

Consent was obtained or waived by all participants in this study

References

  • 1.Total electrical alternans in a patient with malignant pericardial tamponade. Verlaan D, Veltman JD, Grady B. BMJ Case Rep. 2018;2018 doi: 10.1136/bcr-2018-224771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Electrocardiographic changes in pericardial effusion. Meyers DG, Bagin RG, Levene JF. Chest. 1993;104:1422–1426. doi: 10.1378/chest.104.5.1422. [DOI] [PubMed] [Google Scholar]
  • 3.Electrical alternans: a sign, not a diagnosis. Goyal M, Woods KM, Atwood JE. South Med J. 2013;106:485–489. doi: 10.1097/SMJ.0b013e3182a1456c. [DOI] [PubMed] [Google Scholar]
  • 4.The swinging heart: cardiac alternans and right ventricular collapse in classic tamponade. Olearczyk BM, Chongkrairatanakul T, Menzies DJ. Can J Cardiol. 2009;25:240. doi: 10.1016/s0828-282x(09)70080-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Electrical alternans and vulnerability to ventricular arrhythmias. Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. N Engl J Med. 1994;330:235–241. doi: 10.1056/NEJM199401273300402. [DOI] [PubMed] [Google Scholar]
  • 6.Mechanism of electrical alternans in patients with pericardial effusion. Rinkenberger RL, Polumbo RA, Bolton MR, Dunn M. Cathet Cardiovasc Diagn. 1978;4:63–70. doi: 10.1002/ccd.1810040109. [DOI] [PubMed] [Google Scholar]
  • 7.Cardiac tamponade revisited: a postmortem look at a cautionary case. Ariyarajah V, Spodick DH. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1995065/ Tex Heart Inst J. 2007;34:347–351. [PMC free article] [PubMed] [Google Scholar]
  • 8.Neoplastic cardiac tamponade. Osawa T, Tajiri K. Intern Med. 2023;62:2447–2448. doi: 10.2169/internalmedicine.1294-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Pericardial tamponade, a diagnostic chameleon: from the historical perspectives to contemporary management. Kaemmerer AS, Alkhalaileh K, Suleiman MN, et al. J Cardiothorac Surg. 2023;18:60. doi: 10.1186/s13019-023-02174-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Management of cardiac tamponade: a comperative study between echo-guided pericardiocentesis and surgery-a report of 100 patients. Gumrukcuoglu HA, Odabasi D, Akdag S, Ekim H. Cardiol Res Pract. 2011;2011 doi: 10.4061/2011/197838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Treatment of acute cardiac tamponade: a retrospective analysis of classical intermittent versus continuous pericardial drainage. Stremmel C, Scherer C, Lüsebrink E, et al. Int J Cardiol Heart Vasc. 2021;32 doi: 10.1016/j.ijcha.2021.100722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Malignant cardiac tamponade from non-small cell lung cancer: case series from the era of molecular targeted therapy. Li BT, Pearson A, Pavlakis N, et al. J Clin Med. 2014;4:75–84. doi: 10.3390/jcm4010075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Management of malignant pericardial effusion. Petrofsky M. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457183/ J Adv Pract Oncol. 2014;5:281–289. [PMC free article] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES